Medication info

Lukio Searip 4 mg (Montelukast Sodium)

Prescription medicationOral
Ingredient · strength
Montelukast Sodium›4.16mg / 1 packet
Manufacturer / importer
HK inno.N Co., Ltd.
Appearance
Homogeneous white granules without impurities
Packaging
28 packets
Approval status
Active

MFDS item code 201603071 · Approved 2016.05.30 · Insurance code 640007001

Summary

Main use
Prevention and treatment of asthma; relief of seasonal and perennial allergic rhinitis symptoms
Who takes it
Adults · Children
Adult dose
This medicine should be taken once daily. Patients with asthma should take it in the evening, while the dosing time for patients with allergic rhinitis should be determined according to the patient's condition. Patients with both asthma and allergic rhinitis should take 1 tablet, 1 sachet, or 1 film once daily in the evening. ○ How to take the granules (granules only) The 4 mg granules of this medicine may be taken directly by mouth or mixed with a small amount (approximately 5 mL) of soft food, such as room-temperature or cooler baby food, breast milk, or porridge. Do not open the package until immediately before use. After opening, take the entire dose immediately (within 15 minutes), either mixed with baby food, breast milk, or food, or directly. Do not leave this medicine mixed with baby food, breast milk, or food for a prolonged period, and discard any leftover portion. This formulation is not intended to be mixed with beverages other than baby food or breast milk, but a beverage may be taken immediately after administration. This medicine may be taken regardless of meal times.
Child dose
Asthma or allergic rhinitis: 4 mg granules Asthma Children aged 2~5 years: Administer 4 mg of montelukast orally once daily. Infants aged 12 months~under 2 years: Administer 4 mg of this medicine orally once daily in the evening. Efficacy and safety for asthma have not been established in infants under 12 months of age. Allergic rhinitis Children aged 2~5 years: Administer 4 mg of montelukast orally once daily. Efficacy and safety for seasonal allergic rhinitis have not been established in infants under 2 years of age. Infants aged 6 months~under 2 years: Administer 4mg of this medicine orally once daily. Efficacy and safety for perennial allergic rhinitis have not been established in infants under 6 months of age.

Ingredients

Manufacturer
HK inno.N Co., Ltd.

Efficacy & effects

Prevention and treatment of asthma; relief of seasonal and perennial allergic rhinitis symptoms

  • Asthma
  • allergic rhinitis symptoms
View approved original text

This medication is used to prevent asthma attacks and to provide ongoing treatment for asthma. It also helps alleviate symptoms of seasonal and perennial allergic rhinitis.

How to take

Adult dose

This medicine should be taken once daily. Patients with asthma should take it in the evening, while the dosing time for patients with allergic rhinitis should be determined according to the patient's condition. Patients with both asthma and allergic rhinitis should take 1 tablet, 1 sachet, or 1 film once daily in the evening. ○ How to take the granules (granules only) The 4 mg granules of this medicine may be taken directly by mouth or mixed with a small amount (approximately 5 mL) of soft food, such as room-temperature or cooler baby food, breast milk, or porridge. Do not open the package until immediately before use. After opening, take the entire dose immediately (within 15 minutes), either mixed with baby food, breast milk, or food, or directly. Do not leave this medicine mixed with baby food, breast milk, or food for a prolonged period, and discard any leftover portion. This formulation is not intended to be mixed with beverages other than baby food or breast milk, but a beverage may be taken immediately after administration. This medicine may be taken regardless of meal times.

Child dose

Asthma or allergic rhinitis: 4 mg granules Asthma Children aged 2~5 years: Administer 4 mg of montelukast orally once daily. Infants aged 12 months~under 2 years: Administer 4 mg of this medicine orally once daily in the evening. Efficacy and safety for asthma have not been established in infants under 12 months of age. Allergic rhinitis Children aged 2~5 years: Administer 4 mg of montelukast orally once daily. Efficacy and safety for seasonal allergic rhinitis have not been established in infants under 2 years of age. Infants aged 6 months~under 2 years: Administer 4mg of this medicine orally once daily. Efficacy and safety for perennial allergic rhinitis have not been established in infants under 6 months of age.

Precautions

This medication contains the artificial sweetener aspartame, so it is important not to use it in patients with a genetic disorder called phenylketonuria. The aspartame in this medicine is broken down into phenylalanine in the body, so it should not be administered to patients who need to limit their intake of phenylalanine. Patients should also take care not to exceed the daily allowable intake of aspartame, which should not exceed 2.4 grams per day for adults. Those with hypersensitivity to this medication should not use it, and it contains lactose, so patients with lactose intolerance or related genetic disorders should also refrain from taking it. This medication is not for use during acute asthma attacks, and appropriate emergency medications should always be prepared during acute symptoms. When reducing the dose of inhaled corticosteroids, adjustments should be made gradually, following the doctor's instructions, and not suddenly. During the use of this medication, neuropsychiatric symptoms, such as restlessness, anxiety, depression, and hallucinations may occur, and patients should inform their doctor of any such changes. Do not use this medication alone to treat exercise-induced bronchospasm, and inhaled β-agonists should be used as needed. Patients with hypersensitivity to aspirin or non-steroidal anti-inflammatory drugs should avoid using these medications while taking this medication. In rare cases among asthma patients, eosinophilia and vasculitis may occur, so physicians should carefully monitor the patient's condition. No significant interactions have been reported when this medication is used with other medications, but monitoring by a doctor may be necessary when used in combination with certain drugs. Pregnant or nursing women should consult a doctor before taking this medication, as no major abnormalities were noted in animal studies, but safety in humans has not been fully established. It is also available for use in children and the elderly, but safety and efficacy have not been established in children under 6 months or patients with allergic rhinitis under 6 months of age. There is no specific antidote for overdose, so general treatment and monitoring based on symptoms are necessary, and severe symptoms require immediate medical attention. This medication is sensitive to light, so it should be opened just before use, taken immediately after preparation, and stored out of reach of children. Finally, this medication should be taken continuously even when asthma symptoms are absent, and if symptoms worsen or abnormal symptoms appear, medical consultation should be sought immediately.

Side effects

  • Asthenia
  • fatigue
  • fever
  • abdominal pain
  • trauma
  • dyspepsia
  • infectious gastroenteritis
  • toothache
  • dizziness
  • headache
Show 87 more
  • nasal congestion
  • cough
  • influenza
  • rash
  • increased ALT
  • increased AST
  • pyuria
  • pharyngitis
  • sinusitis
  • nausea
  • diarrhea
  • loss of appetite
  • otitis
  • viral infection
  • laryngitis
  • rhinitis
  • chickenpox
  • gastroenteritis
  • atopic dermatitis
  • acute bronchitis
  • dental infection
  • skin infection
  • myopia
  • ear pain
  • enteritis
  • eczema
  • urticaria
  • pneumonia
  • dermatitis
  • conjunctivitis
  • upper respiratory tract infection
  • wheezing
  • otitis media
  • tonsillitis
  • aggressive behavior
  • restlessness
  • anxiety
  • depression
  • disorientation
  • attention deficit
  • sleep disorder
  • hallucinations
  • insomnia
  • memory impairment
  • psychomotor hyperactivity
  • somnambulism
  • suicidal ideation
  • tics
  • drowsiness
  • perceptual abnormalities
  • perceptual decline
  • convulsive seizures
  • palpitations
  • nosebleed
  • pulmonary eosinophilia
  • vomiting
  • cholestatic hepatitis
  • hepatocellular liver injury
  • mixed liver injury
  • vascular edema
  • bruising
  • erythema multiforme
  • nodular erythema
  • itching
  • toxic epidermal necrolysis
  • Stevens-Johnson syndrome
  • arthralgia
  • muscle cramps
  • myalgia
  • enuresis
  • edema
  • thrombocytopenia
  • increased frequency of bleeding
  • hypersensitivity reactions
  • restlessness
  • anxiety
  • depression
  • disorientation
  • attention deficit
  • sleep disorders
  • hallucinations
  • insomnia
  • memory impairment
  • psychomotor hyperactivity
  • somnambulism
  • suicidal ideation and behavior
  • tics

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be protected from moisture and light, and stored at room temperature between 1°C and 30°C. It is also important to keep it in a tightly closed container to prevent air exposure.

Appearance and packaging

Appearance

Homogeneous white granules without impurities

Package unit

28 packets

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.